Patients with cancer who have a stroke are at high risk for a future stroke or other blood clotting problems. These patients are routinely treated with blood thinners such as aspirin or enoxaparin. However, it is unclear which medicine is best.
In this study, investigators are comparing aspirin versus enoxaparin in people with cancer who recently had a stroke, and to see if it is possible to do clinical trials comparing blood thinners in this patient population. Patients will receive either a subcutaneous (under the skin) injection of enoxaparin twice a day, or aspirin (by mouth) every day for six months, and researchers will compare the two groups.